Influence of Exceptional Patient Characteristics on Everolimus Exposure
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Pharmacokinetics
- Acronyms INPRES
- 13 Oct 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
- 13 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Sep 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2018.